Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00218777 · ClinicalTrials.gov registry record · Phase 2
Cognitive Behavior Therapy and Habit Reversal Training for the Treatment of Chronic Tic Disorders in Children
A Phase 2 study of Tourette Syndrome and Tic Disorders, sponsored by Tourette Association of America.
- Completed
- Registry status
- Phase 2
- Development phase
- 120
- Enrollment target
- 3
- Study locations
NCT00218777: Completed Phase 2 study of Tourette Syndrome and Tic Disorders, sponsored by Tourette Association of America.
NCT00218777 is a Phase 2 study of Tourette Syndrome and Tic Disorders that has completed, run by Tourette Association of America. The registered enrollment target is 120 participants, above the 83-participant average among 33 other Tourette Syndrome trials with a reported enrollment target (45% higher). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00218777, a Phase 2 study of Tourette Syndrome and Tic Disorders, has completed, sponsored by Tourette Association of America.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 120 participants
- Enrollment target
- 3
- Study locations
Study Summary
This study will determine the effectiveness of cognitive behavior therapy (CBT) with habit reversal training (HRT) in treating chronic tic disorders (CTDs) in children and adolescents.
Conditions Studied
Interventions
- BEHAVIORAL Comprehensive Behavioral Intervention for Tics
Study Locations (3)
California
- UCLA Child OCD, Anxiety, and Tic Disorders Program - Los Angeles
Maryland
- Johns Hopkins University - Baltimore
Wisconsin
- University of Wisconsin-Milwaukee - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2004-12 |
| Est. Completion | 2007-05 |
| Phase | Phase 2 |
What the finished NCT00218777 record still lists
NCT00218777 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, above the 83-participant average among 33 other Tourette Syndrome trials with a reported enrollment target (45% higher).
The record links to 2 conditions, with Tourette Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Comprehensive Behavioral Intervention for Tics is the first listed.
NCT00218777 reports a single indexed study location in California, Maryland, Wisconsin.
Frequently Asked Questions
What is clinical trial NCT00218777 about?
NCT00218777 is a clinical study titled "Cognitive Behavior Therapy and Habit Reversal Training for the Treatment of Chronic Tic Disorders in Children". This study will determine the effectiveness of cognitive behavior therapy (CBT) with habit reversal training (HRT) in treating chronic tic disorders (CTDs) in children and adolescents.
What is the current status of trial NCT00218777?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 120 participants. The study started on 2004-12. Estimated completion is 2007-05.
What conditions does trial NCT00218777 study?
This clinical trial studies the following conditions: Tourette Syndrome, Tic Disorders.
What interventions are being tested in trial NCT00218777?
The interventions under investigation include: Comprehensive Behavioral Intervention for Tics (BEHAVIORAL).
Who is sponsoring clinical trial NCT00218777?
This trial is sponsored by Tourette Association of America, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00218777 being conducted?
This trial has 3 study locations across California, Maryland, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tourette Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00218777's enrollment target sits among peer trials
120 10th of 33 higher than 24 of 33 other Tourette Syndrome trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Tourette Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Multimodal Profiling of Response to Pediatric Comprehensive Behavioral Intervention for Tics
RECRUITING · Phase 2
-
CBIT+TMS R33 Phase
RECRUITING · Phase 2
-
Efficacy and Safety of Gemlapodect (NOE-105) in Adults and Adolescents With Tourette Syndrome
ACTIVE NOT RECRUITING · Phase 2
-
Pramipexole Pilot Phase II Study in Children and Adolescents With Tourette Disorder According to DSM-IV Criteria
COMPLETED · Phase 2
-
Transcranial Magnetic Stimulation (TMS) for Individuals With Tourette's Syndrome
COMPLETED · Phase 2
-
Sensorimotor and Psychosocial Trajectories in Adolescents With Tic Disorder
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia